Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three consecutive sputum inductions with nebulized racemic salbutamol versus hypertonic saline in smear-negative or sputum-scarce pulmonary tuberculosis
TCTR20250201002Phase 3Completed
- Sponsor
- Prince of Songkla University
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of salbutamol in pulmonary tuberculosis (TB) (2 arms), sponsored by Prince of Songkla University. Started Nov 2016; status: completed.
02
Drugs
salbutamol
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on TCTR20250201002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250201002.